Condition: Type 2 Diabetes · Hepatic Steatosis · Sponsor: AdventHealth Translational Research Institute
The overall aim of this study is to investigate the effects of exercise on the amount of glucose that is made by the liver in people with and without Type 2 diabetes (T2D) and hepatic steatosis (fatty liver).
This description comes directly from the study's public registry record.
Recruitment Department · 407-303-7100 · CFD.TRI.Recruitment@AdventHealth.com
Always discuss trial participation with your own doctor first.
| AdventHealth Translational Research Institute | Orlando, Florida, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06993454